Table 3 Prevalence and magnitude of antibody response to merozoite antigens by age group in Purworejo
Season | Antigen | Age group (N) | 1-4 | 5-9 | 10-15 | 16-25 | 26-40 | >40 |
|---|---|---|---|---|---|---|---|---|
Low | PfMSP1-19 | Prevalence | 1.6(62) | 1.3(77) | 7.6(66) | 8.5(71) | 12.7(115) | 22.7(97) |
Mean OD | 0.067 | 0.071 | 0.085 | 0.093 | 0.113 | 0.142 | ||
High | PfMSP1-19 | Prevalence | 5.6(71) | 5.4(74) | 8.1(74) | 18.4(76) | 23.7(118) | 35.1(114) |
Mean OD | 0.081 | 0.091 | 0.104 | 0.133 | 0.154 | 0.192 | ||
Low | PfAMA1 | Prevalence | 3.2(62) | 5.4(77) | 12.1(66) | 12.7(71) | 14.8(115) | 32.0(97) |
Mean OD | 0.059 | 0.064 | 0.085 | 0.093 | 0.101 | 0.148 | ||
High | PfAMA1 | Prevalence | 5.6(71) | 6.8(74) | 6.8(74) | 17.1(76) | 23.7(118) | 41.2(114) |
Mean OD | 0.079 | 0.076 | 0.084 | 0.138 | 0.146 | 0.191 | ||
Low | Combined | Prevalence | 4.8(62) | 9.1(77) | 16.7(66) | 21.1(71) | 30.4(115) | 52.6(97) |
High | Â | Prevalence | 11.2(71) | 18.9(74) | 27.0(74) | 42.1(76) | 50.0(118) | 57.0(114) |